Диссертация (1140054), страница 18
Текст из файла (страница 18)
– Р. 415-21.15. Котова О.В. Тревожные расстройства и нарушения сна // Consilium Medicum.Неврология. Ревматология. (Прил.). – 2012. - № 1. – С. 29–33.10116. Papadimitrious G., Linkowski P. Sleep disturbance in anxiety disorders // Int RevPsychiatry. - 2005. - № 17. – Р. 229–36.17. Brenes G.A., Miller M.E.
et al. Insomnia in older adults with generalized anxietydisorder //Am J Geriatr Psychiatry. - 2009. – Vol. 17 № 6. – Р. 465–72.18. Spielman A., Caruso L., Glovinsky P. A behavioral perspective on insomniatreatment // Psychiatric Clinic of North America. – 1987.
- № 10. – Р. 541-553.19. Schutte-Rodin S., Broch L., Buysse D., Dorsey C., Sateia M. Clinical Guidelinefor the Evaluation and Management of Chronic Insomnia in Adults // Journal of clinicalsleep medicine. – 2008. – Vol. 4. №5. – Р. 487-504.20. Morin C.M., Vallieres A., Guay B., Ivers H., Savard J., Mérette C., Bastien C.,Baillargeon L.Cognitive behavioral therapy, singly and combined with medication, forpersistent insomnia // JAMA. – 2009.
- № 301. – Р. 2005–2015.21. Espie C.A., Inglis S.J., Harvey L. Predicting clinically significant response tocognitive behavior therapy for chronic insomnia in general motor practice: Analyses ofoutcome data at 12 months posttreatment // J Consult Clin Psychol. - 2001. - № 69. – Р.58-66.22. American Academy of Sleep Medicine. The International classification of sleepdisorders [Diagnostic and coding manual]. - U.S.A.: Darien. - 2014.23. Ronald C. Kessler, Patricia A.
Berglund, et.al. Insomnia and the performance ofUS workers: results from the America insomnia survey // Sleep. - 2011. – Vol. 34. № 9.– Р. 1161–1171.24. Полуэктов М.Г., Пчелина П.В. Современные представления о механизмахразвития и методах лечения хронической инсомнии // РМЖ. – 2016. - № 7. – С.448–452.25. Frontier-Brochu E., Beaulieu-Bonneau S., Ivers H., Morin C.M. Insomnia anddaytime cognitive performance: a meta-analysis // Sleep Medicine Reviews.
– 2012. –Vol. 16. № 1. – Р. 83-94.26. Di Meco A., Joshi Y.B., Pratico D. Sleep deprivation impairs memory, taumetabolism, and synaptic integrity of a mouse model of Alzheimer’s disease withplaques and tangles // Neurobiology of Aging. – 2014.
– Vol. 35. № 8. – Р.1813–1820.27. Soehner A.M., Harvey A.G. Prevalence and Functional Consequences of SevereInsomnia Symptoms in Mood and Anxiety Disorders: Results from a NationallyRepresentative Sample // Sleep. – 2012. – Vol. 35. № 10. Р.1367–1375.28. Taylor D.J., Mallory L.J., Lichstein K.L., et al. Comorbidity of chronic insomniawith medical problems // Sleep. – 2007.
- № 30. – Р. 213−8.29. Полуэктов М.Г., Пчелина П.В. Вторична ли вторичная инсомния //Медицинский совет. – 2014. - № 18. – Р. 51-58.30. Winkelman J.W., Buxton O.M., Jensen J.E., Benson K.L., O'Connor S.P., WangW., Renshaw P.F. Reduced brain GABA in primary insomnia: preliminary data from 4Tproton magnetic resonance spectroscopy (1H-MRS) // Sleep. – 2008. – Vol.
31. № 11. –102Р. 1499-506.31. Morgan P.T., Pace-Schott E.F., Mason G.F., Forselius E., Fasula M., ValentineG.V., Sanacora G. Cortical GABA levels in primary insomnia // Sleep. – 2012. - № 35. Р. 807-14..32. Perlis M.L., Kehr E.L., Smith M.T., Andrews P.J., Orff H., Giles D.E. Temporaland stagewise distribution of high frequency EEG activity in patients with primary andsecondary insomnia and in good sleeper controls // Journal of Sleep Research.
– 2001. –Vol. 10. № 2. – Р. 9.33. LeBlanc M., Merette C., Savard J., Ivers H., Baillargeon L., Morin C.M. Incidenceand Risk Factors of Insomnia in a Population-Based Sample // Sleep. – 2009. – Vol. 32.№ 8. – Р. 1027-1037..34. Vgontzas A.N., Tsigos C., Bixler E.O., Stratakis C.A., Zachman K., Kales A.,Vela-bueno A., Chrousos G.P.
Chronic insomnia and stress systems: a preliminary study// Journal of Psychosomatic Research. – 1998. – Vol. 45. № 1. – Р. 21–31.35. Vgontzas A.N., Liao D., Bixler E.O., Lin H.-M., Prolo P., Mastorakos G., KalesA., Vela-bueno A., Chrousos G.P. Chronic Insomnia Is Associated with NyctohemeralActivation of the Hypothalamic-Pituitary-Adrenal Axis: Clinical Implications // J ClinEndocrinol Metab. – 2001. - № 86. – Р. 3787–9436. Backhaus J., Junghanns K., Hohagen F. Sleep disturbances are correlated withdecreased morning awakening salivary cortisol // Psychoneuroendocrinology. – 2004.
№ 29.- Р.1184–1191.37. Bonnet M.H., Arrand D.L. Physiological activation in patients with sleep-statemisperception // Psychosomatic medicine. – 1997. - № 59. – Р. 553-540..38. Fang S-C., Huang C-J., Yang T.-T., Tsai P.-S. Heart rate variability and daytimefunctioning in insomniacs and normal sleepers: Preliminary results // Journal ofPsychosomatic Research.
– 2008. - № 65. – Р. 23–30..39. Stringhini S., Haba-rubio J., Marques-Vidal P., et.al. Association ofsocioeconomic status with sleep disturbances in the Swiss population-based CoLausstudy // Sleep Med. – 2015. – Vol. 16. № 4. – Р. 469-76.40. Palagini L., Biber K., Riemann D. The genetics of insomnia - Evidence forepigenetic mechanisms? // Sleep Medicine Reviews.
– 2014. - № 18. – Р. 225-235..41. Bastien C. Insomnia: Neurophysiological and Neuropsychological Approaches //Neuropsychological Reviews. – 2011. - № 21. Р. 22–40.42. Рассказова Е.И. Нарушения психологической саморегуляции приневротической инсомнии. Диссертация … канд. мед. наук: 19.00.04/ РассказоваЕлена Игоревна. - М., 2008. – 220 C.43. Principles & practice of sleep medicine. [edited by] Kryger M.H., Roth T. Sixthedition. - Philadelphia, PA: Elsevier. - 2016. – 1778 p.44. Ковальзон В.М.
Основы сомнологии. - Москва:Бином. Лаборатория знаний.– 2011. – C. 113-119.10345. Roth T. Insomnia: Definition, Prevalence, Etiology, and Consequences // Journalof Clinical Sleep Medicine. – 2007. - № 3(5 Suppl). – Р. 7–10.46. Altena E., Vrenken H., Van Der Werf Y.D., et.al. Reduced orbitofrontal andparietal gray matter in chronic insomnia: a voxel-based morphometric study // BiologicalPsychiatry. – 2010. - № 67. – Р. 182-185.47. Nofzinger E.A., Buysse D.J., Germain A., et.al. Functional neuroimaging evidencefor hyperarousal in insomnia // American journal of psychiatry. – 2004. - № 161.
– Р.2126-2128..48. Altena E., Van Der Werf Y.D., Sanz-Arigita E.J., et.al. Prefrontal hypoactivationand recovery in insomnia // Sleep. – 2008. - № 31. – Р. 1271-1276.49. Etkin A., Wager T.D. Functional Neuroimaging of Anxiety: A Meta-Analysis ofEmotional Processing in PTSD, Social Anxiety Disorder, and Specific Phobia // TheAmerican Journal of Psychiatry. – 2007. – Vol. 164. № 10. – Р. 1–13.50. Phillips M.L., Ladouceur C.D., Drevets W.C. A neural model of voluntary andautomatic emotion regulation: implications for understanding the pathophysiology andneurodevelopment of bipolar disorder // Mol Psychiatry.
– 2008. - № 13. – Р. 829.51. Gross J.J. Emotion regulation: affective, cognitive, and social consequences //Psychophysiology. – 2002. - № 39. – Р. 281–291.52. Quirk G.J., Mueller D. Neural mechanisms of extinction learning and retrieval //Neuropsychopharmacology. – 2008. - № 33.
– Р. 56–72.53. Shekleton J.A., Flynn-Evans E.E., Miller B., et.al. Neurobehavioral performanceimpairment in insomnia: relationships with self-reported sleep and daytime functioning //Sleep. – 2014. – Vol. 37. № 1. – Р. 107-16.54. Jung C.M., Ronda J.M., Czeisler C.A., Wright K.P. Comparison of sustainedattention assessed by auditory and visual psychomotor vigilance tasks prior to and duringsleep deprivation // Journal of sleep research. – 2011. - № 20.
– Р. 348-355..55. Basta M., Chrousos G.P., Vela-Bueno A., et al. Chronic insomnia and stresssystem // Sleep Med Clin. - 2007. - № 2. – Р. 279-291.56. Varkevisseri M., Kerkhof J.A. Chronic insomnia and performance in a 24-hconstant routine study // Journal of Sleep Research. – 2005. - № 14. – Р. 49–59.57. Ensrud K.E., Blackwell T.L., Mangione C.M., et.al. Central nervous system-activemedications and risk for falls in older women // Journal of American Geriatric Society. –2002. - № 50. – Р. 1629-1637.58.
Pagel J.F., Parnes B.L. Medications for the treatment of sleep disorders: anoverview // Journal of clinical psychiatry. – 2001. - № 3. – Р. 118-125..59. World Health Organization. Assessment of Zopiclone. 34th ECDD - 2006. – 21р.60. Левин Я.И. Клинический опыт применения зопиклона (Релаксон) приинсомнии. Эффективная фармакотерапия // Неврология и психиатрия. – 2011. - №1. – С. 14–20.61. Vinkers C.H., Olivier B. Mechanisms Underlying Tolerance after Long-Term104Benzodiazepine Use: A Future for Subtype-Selective GABA-A Receptor Modulators? //Advances in Pharmacological Sciences.
– 2012. - № 2012. – Р. 1-19.62. Hedden S.L., Kennet J., Lipari R., et.al. Center for Behavioral Health Statisticsand Quality (2015). Behavioral health trends in the United States: Results from the 2014National Survey on Drug Use and Health. - Rockville, MD: Department of Health andHuman Services (HHS). - 2015. – 64p.63. Riemann D., Spiegelhalder K. Orexin receptor antagonists: a new treatment forinsomnia? // Lancet Neurology. - 2014. - № 13.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
